肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2019 ASCO临床实践指南：已切除胆管癌的辅助治疗

2019-03-11 美国临床肿瘤学会

以证据为基础的临床实践指南，协助胆管癌切除患者的临床决策。

中文标题：

2019 ASCO临床实践指南：已切除胆管癌的辅助治疗

英文标题：

Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline

发布机构：

美国临床肿瘤学会

发布日期：

2019-03-11

简要介绍：

以证据为基础的临床实践指南，协助胆管癌切除患者的临床决策。

相关资料下载：
[AttachmentFileName(sort=100, fileName=2019 ASCO临床实践指南：已切除胆管癌的辅助治疗)] GetToolGuiderByIdResponse(projectId=1, id=c62b71c001e67863, title=2019 ASCO临床实践指南：已切除胆管癌的辅助治疗, enTitle=Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline, guiderFrom=, authorId=null, author=, summary=以证据为基础的临床实践指南，协助胆管癌切除患者的临床决策。, cover=, journalId=null, articlesId=null, associationId=8, associationName=美国临床肿瘤学会, associationIntro=美国临床肿瘤学会（ASCO，American Society of Clinical Oncology）是一个成立于1964年的非营利性组织，总目标是改善肿瘤的监护与预防。目前已有27000名肿瘤科医师加入了ASCO，分属各个肿瘤专科和亚专科。会员包括在肿瘤治疗各个层次的医师和卫生保健专业人员。ASCO由一个有19名成员的当选董事会管理，该学会的大部分业务是由志愿为学会项目花费时间和出力的ASCO会员组成的各种委员会处理的。患者支持团体的领导也经常活跃于ASCO委员会中。目前有22个由ASCO的全职人员管理和支持的委员会。, copyright=0, guiderPublishedTime=Mon Mar 11 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<span style="color: rgb(46, 48, 51); font-family: Arial, 'Microsoft YaHei', 微软雅黑, 宋体, 'Malgun Gothic', Meiryo, sans-serif; font-size: 14px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); display: inline !important; float: none;">以证据为基础的临床实践指南，协助胆管癌切除患者的临床决策。</span>, tagList=[], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=91, categoryName=肝胆胰外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2844, appHits=328, showAppHits=16, pcHits=1686, showPcHits=1638, likes=56, shares=8, comments=12, approvalStatus=1, publishedTime=Fri Jul 26 16:36:42 CST 2019, publishedTimeString=2019-03-11, pcVisible=1, appVisible=1, editorId=5296140, editor=Vina2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=Vina2, createdTime=Fri Jul 26 16:36:42 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 10:31:57 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 ASCO临床实践指南：已切除胆管癌的辅助治疗)])
2019 ASCO临床实践指南：已切除胆管癌的辅助治疗
下载请点击：
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1228242, encodeId=41ea122824284, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7d25091682, createdName=145d4c03m99暂无昵称, createdTime=Thu Jun 23 16:33:32 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063430, encodeId=aa9e106343079, content=下载文件来的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46ae2574153, createdName=1258d185m37暂无昵称, createdTime=Sun Oct 24 12:24:52 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926781, encodeId=6127926e819d, content=内容已损坏 ？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Wed Feb 24 08:44:51 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926780, encodeId=a74f926e8083, content=谢谢平台提供这么方便的学习平台，受教了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Wed Feb 24 08:44:00 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918288, encodeId=fa1d918288ab, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/18/4904f1f58fd84759f4600a01d3817b4f.jpg, createdBy=f68b2548802, createdName=12539c47m51暂无昵称, createdTime=Wed Jan 20 09:33:54 CST 2021, time=2021-01-20, status=1, ipAttribution=)]
    2022-06-23 145d4c03m99暂无昵称

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1228242, encodeId=41ea122824284, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7d25091682, createdName=145d4c03m99暂无昵称, createdTime=Thu Jun 23 16:33:32 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063430, encodeId=aa9e106343079, content=下载文件来的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46ae2574153, createdName=1258d185m37暂无昵称, createdTime=Sun Oct 24 12:24:52 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926781, encodeId=6127926e819d, content=内容已损坏 ？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Wed Feb 24 08:44:51 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926780, encodeId=a74f926e8083, content=谢谢平台提供这么方便的学习平台，受教了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Wed Feb 24 08:44:00 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918288, encodeId=fa1d918288ab, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/18/4904f1f58fd84759f4600a01d3817b4f.jpg, createdBy=f68b2548802, createdName=12539c47m51暂无昵称, createdTime=Wed Jan 20 09:33:54 CST 2021, time=2021-01-20, status=1, ipAttribution=)]
    2021-10-24 1258d185m37暂无昵称

    下载文件来的

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1228242, encodeId=41ea122824284, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7d25091682, createdName=145d4c03m99暂无昵称, createdTime=Thu Jun 23 16:33:32 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063430, encodeId=aa9e106343079, content=下载文件来的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46ae2574153, createdName=1258d185m37暂无昵称, createdTime=Sun Oct 24 12:24:52 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926781, encodeId=6127926e819d, content=内容已损坏 ？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Wed Feb 24 08:44:51 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926780, encodeId=a74f926e8083, content=谢谢平台提供这么方便的学习平台，受教了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Wed Feb 24 08:44:00 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918288, encodeId=fa1d918288ab, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/18/4904f1f58fd84759f4600a01d3817b4f.jpg, createdBy=f68b2548802, createdName=12539c47m51暂无昵称, createdTime=Wed Jan 20 09:33:54 CST 2021, time=2021-01-20, status=1, ipAttribution=)]
    2021-02-24 牛

    内容已损坏 ？

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1228242, encodeId=41ea122824284, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7d25091682, createdName=145d4c03m99暂无昵称, createdTime=Thu Jun 23 16:33:32 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063430, encodeId=aa9e106343079, content=下载文件来的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46ae2574153, createdName=1258d185m37暂无昵称, createdTime=Sun Oct 24 12:24:52 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926781, encodeId=6127926e819d, content=内容已损坏 ？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Wed Feb 24 08:44:51 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926780, encodeId=a74f926e8083, content=谢谢平台提供这么方便的学习平台，受教了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Wed Feb 24 08:44:00 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918288, encodeId=fa1d918288ab, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/18/4904f1f58fd84759f4600a01d3817b4f.jpg, createdBy=f68b2548802, createdName=12539c47m51暂无昵称, createdTime=Wed Jan 20 09:33:54 CST 2021, time=2021-01-20, status=1, ipAttribution=)]
    2021-02-24 牛

    谢谢平台提供这么方便的学习平台，受教了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1228242, encodeId=41ea122824284, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7d25091682, createdName=145d4c03m99暂无昵称, createdTime=Thu Jun 23 16:33:32 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063430, encodeId=aa9e106343079, content=下载文件来的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46ae2574153, createdName=1258d185m37暂无昵称, createdTime=Sun Oct 24 12:24:52 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926781, encodeId=6127926e819d, content=内容已损坏 ？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Wed Feb 24 08:44:51 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926780, encodeId=a74f926e8083, content=谢谢平台提供这么方便的学习平台，受教了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Wed Feb 24 08:44:00 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918288, encodeId=fa1d918288ab, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/18/4904f1f58fd84759f4600a01d3817b4f.jpg, createdBy=f68b2548802, createdName=12539c47m51暂无昵称, createdTime=Wed Jan 20 09:33:54 CST 2021, time=2021-01-20, status=1, ipAttribution=)]
    2021-01-20 12539c47m51暂无昵称

    学习了

    0

以上为热门评论，梅斯医学App还有更多内容